Skip to Content
Merck
CN
  • Chronic exposure to cannabinoids during adolescence causes long-lasting behavioral deficits in adult mice.

Chronic exposure to cannabinoids during adolescence causes long-lasting behavioral deficits in adult mice.

Addiction biology (2016-09-01)
J Tomas-Roig, E Benito, R C Agis-Balboa, F Piscitelli, S Hoyer-Fender, V Di Marzo, U Havemann-Reinecke
ABSTRACT

Regular use of marijuana during adolescence enhances the risk of long-lasting neurobiological changes in adulthood. The present study was aimed at assessing the effect of long-term administration of the synthetic cannabinoid WIN55212.2 during adolescence in young adult mice. Adolescent mice aged 5 weeks were subjected daily to the pharmacological action of WIN55212.2 for 3 weeks and were then left undisturbed in their home cage for a 5-week period and finally evaluated by behavioral testing. Mice that received the drug during adolescence showed memory impairment in the Morris water maze, as well as a dose-dependent memory impairment in fear conditioning. In addition, the administration of 3 mg/kg WIN55212.2 in adolescence increased adult hippocampal AEA levels and promoted DNA hypermethylation at the intragenic region of the intracellular signaling modulator Rgs7, which was accompanied by a lower rate of mRNA transcription of this gene, suggesting a potential causal relation. Although the concrete mechanisms underlying the behavioral observations remain to be elucidated, we demonstrate that long-term administration of 3 mg/kg of WIN during adolescence leads to increased endocannabinoid levels and altered Rgs7 expression in adulthood and establish a potential link to epigenetic changes.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2,2,2-Tribromoethanol, 97%
Sigma-Aldrich
Palmitoylethanolamide
Sigma-Aldrich
N-Oleoylethanolamine, ~98% (TLC)
Sigma-Aldrich
Arachidonylethanolamide, ≥97.0% (TLC), oil